Antibiotic Coverage for Cutaneous or Soft‑Tissue Abscess
Primary Treatment: Incision and Drainage Alone
Incision and drainage (I&D) is the definitive treatment for cutaneous abscesses, and antibiotics are not routinely required after adequate drainage of simple abscesses. 1
- I&D should be performed promptly for all cutaneous abscesses, as it is the cornerstone of therapy. 1
- Simply covering the surgical site with dry sterile gauze is adequate; wound packing causes more pain without improving healing and should be avoided. 1
- Needle aspiration is not recommended, with only a 25% success rate overall and less than 10% success with MRSA. 1
When Antibiotics Are NOT Needed
For simple abscesses treated with adequate I&D alone, antibiotics should be omitted to avoid unnecessary contribution to antimicrobial resistance without improving clinical outcomes. 1
- Simple abscesses are defined by induration and erythema limited to the defined abscess area without extension beyond borders, no extension into deeper tissues or multiloculated spread, and absence of systemic signs of infection. 1
- Resolution rates after I&D alone are 93–96%, demonstrating that antibiotics are unnecessary in uncomplicated cases. 2
When to Add Antibiotics: High‑Risk Situations
Add systemic antibiotics when any of the following high‑risk features are present: 1
- Systemic inflammatory response syndrome (SIRS): temperature >38°C or <36°C, tachypnea >24 breaths/min, tachycardia >90 beats/min, or WBC >12,000 or <4,000 cells/µL 1
- Severe or extensive disease involving multiple infection sites 1
- Rapid progression with associated cellulitis 1
- Immunocompromised patients (diabetes, HIV, malignancy, immunosuppressive drugs) 1
- Extremes of age 1
- Abscess in difficult‑to‑drain areas (face, hands, genitalia) 1
- Associated septic phlebitis 1
- Incomplete source control after drainage 1
- Lack of response to I&D alone 1
First‑Line Oral Antibiotic Regimens (When Indicated)
For outpatient empiric coverage of community‑acquired MRSA, choose one of the following: 1
- Trimethoprim‑sulfamethoxazole (TMP‑SMX): 160–320/800–1600 mg (1–2 double‑strength tablets) PO every 12 hours 3, 1
- Clindamycin: 300–450 mg PO every 6–8 hours (provides single‑agent coverage for both MRSA and streptococci, but use only if local clindamycin resistance <10%) 3, 1
- Doxycycline: 100 mg PO every 12 hours 3, 1
- Minocycline: 200 mg loading dose, then 100 mg PO every 12 hours 3
- Linezolid: 600 mg PO every 12 hours (reserved for complicated cases due to cost) 3, 1
Inpatient IV Antibiotic Regimens (Complicated Abscesses)
For hospitalized patients with complicated skin and soft tissue infections requiring IV therapy: 3
- Vancomycin: 30–60 mg/kg/day IV in two to four divided doses (loading dose of 25–30 mg/kg for seriously ill patients) 3
- Teicoplanin: 6–12 mg/kg/dose IV every 12 hours for three doses, then once daily 3
- Linezolid: 600 mg IV/PO every 12 hours 3
- Daptomycin: 4 mg/kg/dose IV once daily 3
Duration of Antibiotic Treatment
The duration of antibiotic treatment is typically 5–10 days when antibiotics are used. 3, 1
- For uncomplicated cases requiring antibiotics, 5 days is sufficient if clinical improvement occurs. 1
- Extend treatment only if symptoms have not improved within this timeframe. 1
Special Considerations for Complex Abscesses
Complex abscesses (perianal/perirectal locations, IV drug injection sites, or those with significant surrounding cellulitis) require I&D plus empiric broad‑spectrum antibiotics covering Gram‑positive, Gram‑negative, and anaerobic bacteria. 1
- For complex groin or perianal abscesses, the CDC recommends IV clindamycin 900 mg every 8 hours plus gentamicin (2 mg/kg loading dose followed by 1.5 mg/kg every 8 hours). 1
- Perianal/perirectal abscesses should be drained surgically with identification of fistula tracts. 1
- IV drug users require evaluation for endocarditis if systemic signs persist, foreign body removal, and screening for HIV/HCV/HBV. 1
Culture Recommendations
- Gram stain and culture of pus are recommended for carbuncles and abscesses, but treatment without these studies is reasonable in typical cases. 1
- Culture results guide antibiotic adjustment if treatment fails. 1
Critical Pitfalls to Avoid
- Do not use rifampin as single agent or adjunctive therapy for skin abscesses. 1
- Do not routinely prescribe antibiotics for simple abscesses after adequate I&D, as this contributes to resistance without improving outcomes. 1
- Do not pack wounds routinely, as evidence shows no benefit and increased pain. 1
- Do not use fluoroquinolones for MRSA coverage, as they are inadequate. 1
- Do not use ceftriaxone for superficial cutaneous abscesses; it lacks activity against community‑acquired MRSA. 1